Symposium: CAR T Cell Therapy and Advances in Cellular Engineering

Dates: June 6-7, 2023 |
CAR T Cell Therapy and Advances in Cellular Engineering

- Jun. 6, 2023

Event Title:
CAR T Cell Therapy and Advances in Cellular Engineering

Dates:
2023-06-06 - 2023-06-07

Venue Site:
Oticon salen, Technical University of Denmark, 2800 Lyngby, Denmark

Organisers:
Training Network for Optimizing Adoptive T cell Therapy of Cancer (T-OP), Danish CAR-T cell Network (DCTN) and Technical University of Denmark (DTU)

Details:
The field of chimeric antigen receptor (CAR) T cell therapy is rapidly developing offering new therapeutic options for patients with otherwise incurable disease. Despite great progress there is still a need to further develop and mature this technology to secure long-term benefit for all treated patients and sustain the increasing demand for CAR T cell products. On behalf of Training Network for Optimizing Adoptive T cell Therapy of Cancer (T-OP), Danish CAR-T cell Network (DCTN) and Technical University of Denmark (DTU) we are delighted to welcome international experts within the field to discuss the latest advances in CAR T cell therapy and cellular engineering.

International confirmed speakers:

  • Dr. Carl June
  • Dr. Michell Sadelain
  • Dr. Hinrich Abken
  • Dr. Stanley Riddell
  • Dr. Johanna Olweus
  • Dr. Sebastian Kobold
  • Dr. Michael Hudecek

Deadline for Registration:
2023-06-06 or until seating limits is reached

Registration:
https://www.tilmeld.dk/car-t/conference

Tags

HashtagEventsHashtagCancerHashtagAdoptive T cell therapy (ACT)HashtagCAR-THashtagImmunotherapyHashtagTumour-infiltrating lymphocytes (TIL)

Event: Symposium: CAR T Cell Therapy and Advances in Cellular Engineering
Event: Symposium: CAR T Cell Therapy and Advances in Cellular Engineering
CLINICAL TRIALS
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Indicator
IND Enabling
Phase I
Phase II
Phase III
Acute Myeloid Leukemia, AML, (NCT05662904)
Sponsors:
German Cancer Research Center
Indicator
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
close
Search CRISPR Medicine